Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,054,674
Total 13F shares
19,416,540
Share change
+8,604,797
Total reported value
$290,234,810
Price per share
$14.95
Number of holders
64
Value change
+$128,771,717
Number of buys
50
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q3 2017

As of 30 Sep 2017, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,416,540 shares. The largest 10 holders included EcoR1 Capital, LLC, FMR LLC, Partner Fund Management, L.P., GREAT POINT PARTNERS LLC, BVF INC/IL, BlackRock Inc., VANGUARD GROUP INC, Boxer Capital, LLC, Candriam Luxembourg S.C.A., and BANK OF MONTREAL /CAN/. This page lists 64 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.